Home > Books > Book

Cutting-Edge Applications of Nanomaterials in Biomedical Sciences

Pranav Kumar Prabhakar (Department of Biotechnology, Nagaland University, India) and Ajit Prakash (University of North Carolina, USA)
Indexed In: SCOPUS
Release Date: January, 2024 | Copyright: © 2024 | Pages: 605

Publication Status: E-Book and Print Version Available for Purchase
ISBN13: 9798369304488
EISBN13: 9798369304501
DOI: 10.4018/979-8-3693-0448-8

Description:

Cutting-Edge Applications of Nanomaterials in Biomedical Sciences is a comprehensive exploration of the revolutionary impact of nanotechnology on the field of medicine. This book delves into the remarkable potential of nanomaterials in advancing medical diagnostics and therapeutics, particularly in drug delivery. It serves as an indispensable guide, presenting the latest developments in nanomedicine, precision medicine, and nanoengineering while addressing the challenges and opportunities that arise.

The book covers a wide range of topics, from nanomaterials for cancer therapy to their applications in imaging and diagnostics. It discusses the transformative role of nanomaterials in targeted delivery and controlled release, as well as their potential in regenerative medicine and infectious disease diagnosis and treatment. Readers will gain valuable insights into the safety and toxicity concerns associated with nanomaterials and nanomedicine's regulatory and commercialization aspects.

By presenting cutting-edge research and developments in the field, this book aims to bridge the gap between bench and bedside, providing a vital resource for researchers, clinicians, and students in the biomedical sciences. Moreover, it highlights the commercialization potential of nanomedicine, fostering collaboration between academia and industry. Policymakers and regulators will also find this book invaluable for understanding the ethical and safety implications of incorporating nanomaterials into medical practices.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Biomedical Sciences
  • Cancer Therapy
  • Commercialization
  • Controlled Release
  • Diagnostics
  • Drug Delivery
  • Imaging
  • Infectious Diseases
  • Nanomaterials
  • Nanotechnology
  • Precision Medicine
  • Regenerative Medicine
  • Safety and Toxicity
  • Targeted Delivery
  • Therapeutics

Search this Book:
Reset

Indexing

Dr. Pranav Kumar Prabhakar is a Professor and Head of the Department of Biotechnology at Nagaland University, Kohima, India. He earned his PhD in Biotechnology from the prestigious Indian Institute of Technology (IIT) Madras. Dr. Prabhakar is internationally recognized for his contributions to biomedical and biotechnological research and has been consistently listed among the World’s Top 2% Scientists by Stanford University, USA, for five consecutive years (2021–2025). His research primarily focuses on elucidating molecular mechanisms underlying metabolic disorders, particularly diabetes, and developing innovative strategies for oral insulin delivery. He has also made significant contributions to understanding signaling pathways using natural product–based interventions, advancing the scientific community’s knowledge in therapeutic approaches for chronic diseases. Dr. Prabhakar is an active member of the Royal Society of Chemistry (RSC) and the Asia-Pacific Chemical, Biological & Environmental Engineering Society (APCBEES). In addition to his research achievements, he serves on the editorial boards of several reputable international journals and is a regular reviewer for high-impact publications across biotechnology, pharmacology, and biomedical sciences. Over the course of his career, he has authored or edited 22 books, published over 150 research articles, contributed more than 40 book chapters, and presented his work through various oral and poster presentations.
Ajit Prakash, an accomplished researcher, earned his B.Sc. in Biotechnology from Jamia Millia Islamia and M.Sc. in Genomics from Madurai Kamaraj University, India. He obtained his Ph.D. in Biochemistry from Nanyang Technological University, Singapore. Following a postdoctoral fellowship at the University of Cambridge, UK, and a stint as an assistant professor at Lovely Professional University, he pursued a second postdoc at the University of North Carolina, Chapel Hill, where he currently works as a Research Associate. In his over five years of postdoctoral research, Dr. Ajit has made significant contributions to protein biochemistry and molecular biology, particularly in the field of cancer research. His impact is evident in publishing 17+ high-impact research papers/book chapters. Beyond his research, Dr. Ajit Prakash holds editorial positions in various prestigious journals and also serves as an expert reviewer. He is an esteemed member of the "American Heart Association" and the 'International Natural Product Sciences Taskforce', USA. His journey is a testament to his unwavering commitment to advancing scientific understanding and progress.

All IGI Global Scientific Publishing content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global Scientific Publishing published content is available in the IGI Global Scientific Publishing InfoSci® platform.

We are committed to continually improving our platform to meet WCAG standards. We have used automated scans as well as manual review to identify and resolve compatibility issues. Our goal is to ensure all of our content is easily accessible to all users.

  • Current Accessibility Implementations
  • Screen reader compatible web pages with properly labeled elements.
  • Text alternatives for non-text content so it can be changed into large print, braille, speech, symbols, or simpler language.
  • User interface can be navigated using only a keyboard - no keyboard traps.
  • Consistent navigation on all web pages.
  • Meaningful section heading are used to organize content in a logical manner.
  • Logical focus order of elements on each web page.
  • No web pages contain any flashing, or design elements that are known to cause seizures or physical reactions.
  • Text has high contrast, with a contrast ratio of at least 4.5:1.
  • Responsive design, with text that can be resized without loss of content or functionality.
Learn More